Search

everythinglearnresearchcommunity

for

Search:↓

Most lupus patients in coastal Kerala had skin-specific lesions that could help diagnose the disease, and non-specific skin issues were linked to more severe, systemic lupus.

Children with systemic lupus erythematosus have different skin symptoms than adults.

Cutaneous lupus erythematosus is a common skin condition in lupus, affecting mostly young adult females.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

A woman with lupus developed a rare skin condition, which improved with increased medication.

Most patients with systemic lupus erythematosus in Malwa, India, show skin symptoms like photosensitivity and rashes.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

New treatments and understanding of skin lupus are emerging in 2024.

Skin issues like hair loss, rash, and sensitivity to sunlight are key signs of lupus activity.

Skin problems are common and early signs of Systemic Lupus Erythematosus, and certain immune system markers are important for diagnosis and treatment.

Patients with cutaneous lupus are most concerned about self-consciousness, physical symptoms, and disease progression.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Patients with cutaneous lupus erythematosus have a higher risk of skin cancer and other cancers.

Damage to hair follicle stem cells causes permanent hair loss and scarring in cutaneous lupus erythematosus.

Chronic cutaneous lupus erythematosus causes scarring, hair loss, and skin discoloration, especially on sun-exposed areas.

Patients with cutaneous lupus erythematosus have a severely impaired quality of life, especially emotionally.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Recognizing specific skin features helps diagnose and manage lupus erythematosus effectively.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

Early and accurate diagnosis is crucial for effectively managing hair loss in lupus and alopecia areata.

A multidisciplinary approach is essential for effectively managing cutaneous lupus erythematosus.

Intralesional corticosteroids effectively treat scalp Discoid Lupus and restore hair.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.